CAU
MEDP icon

Caxton Associates (UK)’s Medpace MEDP Stock Holding History

Caxton Associates (UK)’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$375K Hold
708
– – 0.01% 593
2026
Q1 		$340K Sell
708
-175
-20% -$89.6K 0.01% 578
2025
Q4 		$496K Sell
883
-19,921
-96% -$11.3M 0.01% 504
2025
Q3 		$10.7M Buy
+20,804
New +$9.08M 0.25% 37

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Caxton Associates (UK)'s MEDP Position: Q2 2026 in Review

Caxton Associates (UK) held its Medpace (MEDP) position steady in Q2 2026 at 708 shares worth $375K. The position accounts for 0.01% of the portfolio, ranked #593.

Caxton Associates (UK) first reported a position in MEDP in Q3 2025 and has held it in 4 quarters since. The position peaked at $10.7M in Q3 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Caxton Associates (UK) held 708 shares of Medpace worth $375K as of Q2 2026.
  • Caxton Associates (UK) left its Medpace share count unchanged in Q2 2026.
  • Medpace made up 0.01% of Caxton Associates (UK)'s portfolio in Q2 2026, its #593 holding.
  • Caxton Associates (UK) first reported a position in Medpace in Q3 2025 and has held it in 4 quarters since.
  • Caxton Associates (UK)'s Medpace position peaked at $10.7M in Q3 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.